Boundary Genesis Omega v43: Universal Null–Void Ceiling, Recoverability-Constrained Meta-Science, and Terminal Material Closure

Abstract

Boundary Genesis Omega v43 presents an executable research-governance architecture for distinguishing mathematical closure, evidentiary sufficiency, scientific uncertainty, and terminal material closure within a recoverability-constrained research system. The edition introduces a Universal Null–Void Ceiling that prevents unsupported conclusions from being promoted into scientific, clinical, legal, or operational authority. It provides explicit classification of evidence states, scope-bounded closure rules, deterministic audit procedures, reopening conditions, and human-first safeguards. The architecture extends the available Boundary Genesis Omega v41–v42 research components and incorporates the Null–Void Ceiling as a governing constraint on formal reasoning and research claims. Its primary application context is the evaluation of scientific hypotheses and causal assumptions associated with human vision restoration, including biological mechanisms, neural pathways, implantable technologies, computational models, and human-machine research systems. The edition does not claim that human vision restoration has been achieved, that a novel biological mechanism has been experimentally demonstrated, or that all scientific possibilities have been exhausted. 1. Research problem Complex scientific and computational systems may generate large numbers of hypotheses, combinations, mathematical derivations, simulations, and apparent discoveries. However, formal completeness within a specified model does not establish completeness of physical reality. A system may exhaust a finite combination space while leaving fundamental questions unresolved concerning biological mechanisms, experimental reproducibility, measurement validity, causal identification, patient-specific variation, and clinical effectiveness. Boundary Genesis Omega v43 addresses the risk of confusing these different forms of closure. It establishes explicit conditions under which a claim must remain open, may be provisionally closed within a defined scope, or must be reopened following new material evidence. 2. Universal Null–Void Ceiling The Universal Null–Void Ceiling defines the limit beyond which the system cannot legitimately assert conclusions from its available records. The architecture distinguishes six evidentiary states: NULL: No evidence is recorded. VOID: No admissible successor exists within the declared model. UNKNOWN: Evidence is available, but it is insufficient to justify a definite conclusion. CONTRADICTORY: The available evidence contains unresolved conflicts. REFUTED: Explicit counterevidence is recorded. SUPPORTED: The record explicitly documents adequate evidence, validated measurement, and independent replication. These classifications concern the contents and sufficiency of supplied research records. They are not independent certifications of external scientific truth. The Null–Void Ceiling prevents absence of evidence, unmeasured conditions, or computational silence from being interpreted as proof of nonexistence, biological failure, clinical effectiveness, or consent. 3. Terminal material closure Terminal material closure is defined as a scope-bounded determination rather than universal scientific finality. A record may be materially closed only when its required information is present and its documented scope meets one of the permitted terminal conditions: VOID, REFUTED, or SUPPORTED. Records containing unresolved uncertainty or contradictory evidence remain open. Every materially closed record remains reopenable when new evidence changes the relevant distinction. The architecture explicitly rejects the assertion that all scientific possibilities have been exhausted. 4. Recoverability-constrained governance The framework applies human-first governance requirements to research classification, computational inference, scientific communication, and possible future clinical applications. Its safeguards include: Silence must not be interpreted as consent. Unknown biological states must not be classified as intact. Absence of evidence must not be interpreted as proof of nonexistence. Simulations must not be represented as clinical demonstrations. No automatic authorization for human intervention is permitted. Mathematical enumeration must not be represented as exhaustive biological knowledge. Conclusions must remain bounded by their documented scope. Counterexamples and contradictory records must be preserved. Clinical claims require human expert review. Material new evidence must permit reopening. These principles preserve the distinction between scientific exploration and authorized intervention. 5. Scientific and interdisciplinary scope The research architecture identifies material evidence gaps across twelve domains: Mathematics and formal models Meta-laws and foundational assumptions Derivations and proof obligations Biological mechanisms Neural and visual pathways Implantable and assistive technologies Artificial intelligence and computational systems Clinical evidence Governance and authorization Ethics and informed consent Measurement and experimental validation Scientific novelty and independent verification The architecture is intended to support structured scientific scrutiny rather than substitute for experimental investigation. 6. Executable software components The distribution includes Python research engines, executable tests, documentation, and a machine-readable material-gap register. The v43 component provides commands for: Displaying the supported research domains. Generating a structured research-record template. Auditing an input record against the Null–Void evidence classification. Producing a machine-readable audit result. Verifying the integrity of an audit record. Running deterministic software tests. The included v41 and v42 components are preserved as earlier research layers. The archive does not contain every historical Boundary Genesis Omega edition. 7. Formal closure versus scientific discovery The software implements deterministic evidence-state classification and scope-bounded closure rules. Successful execution establishes behavior of the implemented program under its tests. It does not independently establish the truth of the submitted evidence, the validity of an experimental hypothesis, or the effectiveness of a medical intervention. In particular, the archive does not demonstrate a new treatment capable of restoring human vision. Any proposed biological or technological breakthrough requires appropriate experimental evidence, independent replication, functional outcome assessment, and applicable ethical and regulatory authorization. 8. Non-circular stopping and reopening The architecture introduces a non-circular stopping principle. A research branch should stop when the same evidence, assumptions, and predictions are repeated without producing a material distinction. The branch may reopen when new observations, independent replication, counterexamples, distinct falsifiable predictions, or relevant changes in human needs and preferences become available. The stopping condition therefore limits unsupported recursive assertion without permanently prohibiting future discovery. 9. Relationship to Recoverability-Constrained Systems and Continuity Science Boundary Genesis Omega v43 is presented as a domain-specific research-software contribution within the wider Recoverability-Constrained Systems and Continuity Science corpus associated with Noelia Sanchez and Interval Studio. Its Null–Void Ceiling is intended to connect finite successor-space reasoning, recoverability-constrained admissibility, recursive governance, evidentiary distinction, and terminal closure. The edition operationalizes the principle that computational closure must remain separate from scientific certainty and human authorization. 10. Reproducibility The archive provides executable Python components and deterministic tests. Users can generate research templates, evaluate structured records, inspect audit outcomes, and verify recorded audit integrity. Reproducibility of the software is distinct from independent reproduction of biological or clinical findings. 11. Limitations The distribution is a research-governance and methodological software artifact. It is not a medical device, a clinically validated diagnostic system, an autonomous laboratory, or an authorization framework for human experimentation. It does not establish universal scientific completeness, experimentally verified biological discoveries, or regulatory approval. Evidence classifications depend on the supplied records and the implemented rules. 12. Terminal material-closure determination The edition reaches a defined software-level stopping boundary. The declared evidence states, classification procedures, and closure conditions are implemented within the available research package. Unresolved scientific evidence gaps remain open. The system must not promote unsupported conclusions beyond the available evidence. The recorded stopping reason is the absence of a new material distinction sufficient to justify stronger claims. Future research remains admissible when genuinely new evidence, reproducible counterexamples, independent experiments, or meaningful changes in human needs arise. Final determination: Formal software closure within the declared scope; scientific and clinical discovery remain open.